Takeda Pharmaceutica

4502
End-of-day quote Tokyo - 02/19
4500JPY
-0.18%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Sales per Businesses
20172018
JPY
(in Million)
%JPY
(in Million)
%
Prescription Drug1,568,87090.6%--
Consumer Healthcare82,5724.8%--
Other80,6074.7%--
Pharmaceutical--1,693,84095.7%
Intellectual Property Rights and Services--76,6934.3%
Sales per Regions
20172018
JPY
(in Million)
%JPY
(in Million)
%
Japan655,34437.8%580,34932.8%
United States520,16130%598,34133.8%
Europe and Canada279,69316.1%313,72317.7%
Asia112,7996.5%104,0265.9%
Latin America72,5164.2%75,6584.3%
Russia / Commonwealth of Independent States57,5503.3%68,2403.9%
Other33,9872%30,1941.7%
Managers
Name Title
Christophe Weber President, CEO & Representative Director
Costa Saroukos Chief Financial Officer
Andrew S. Plump Director, Chief Medical & Scientific Officer
Yasuhiko Yamanaka Managing Director & Head-Globalization
Masato Iwasaki Director & President-Japan Pharma Business Unit
Masahiro Sakane Independent Outside Director
Shiro Kuniya Independent Outside Director
Yoshiaki Fujimori Independent Outside Director
Emiko Higashi Independent Outside Director
Michel Orsinger Independent Outside Director
Shareholders
Name Equities %
Mondrian Investment Partners Ltd. 2,873,870 0.18%
Parametric Portfolio Associates LLC 1,971,498 0.12%
Causeway Capital Management LLC 1,102,192 0.069%
Exane Asset Management SA 933,466 0.059%
Janus Capital Management LLC 682,332 0.043%
Glenmede Investment Management LP 370,991 0.023%
Oppenheimer Asset Management, Inc. 310,161 0.020%
Kepos Capital LP 150,000 0.0094%
TD Waterhouse Private Investment Counsel, Inc. 126,895 0.0080%
Pacer Advisors, Inc. 109,912 0.0069%
Company contact information
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka
Japan

Phone : +81 6 6204 2111
Fax : +81 6 6204 2880
Internet : http://www.takeda.co.jp
Markets and indexes
- Tokyo Stock Exchange
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- ISIN Code :  JP3463000004
- Bloomberg Code :  4502:JP
- Reuters Code :  4502.T
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL CO LTD24.31%63 728
JOHNSON & JOHNSON5.68%365 768
PFIZER-2.86%245 920
ROCHE HOLDING LTD.12.28%233 628
NOVARTIS7.14%228 516
MERCK AND COMPANY3.70%207 536
ELI LILLY AND COMPANY5.84%129 746
AMGEN-3.25%117 200
SANOFI-1.31%106 226
GLAXOSMITHKLINE5.32%100 619
ASTRAZENECA3.75%100 537
NOVO NORDISK11.61%96 283
BRISTOL-MYERS SQUIBB COMPANY-0.60%84 336
BAYER11.96%71 793
CELGENE CORPORATION41.50%63 415
ALLERGAN PLC3.22%46 257
JIANGSU HENGRUI MEDICINE CO.26.69%36 342
CHUGAI PHARMACEUTICAL CO LTD15.21%35 794
ASTELLAS PHARMA INC22.30%30 215
DAIICHI SANKYO COMPANY, LIMITED11.53%24 324
EISAI CO., LTD5.76%23 467
Brand Portfolio
INVIRAGEN
INVIRAGEN
SHIRE
SHIRE
TAKEDA
TAKEDA
More brands of Takeda Pharmaceutical Co Ltd